Track the Cochlear Limited share price and the full directors' dealings record of the company, a listed equity based in Australia. Shares are listed on the AU market, under the oversight of ASX. Operating in the Health Care sector, Cochlear Limited has logged 21 public disclosures. Market capitalisation: €8.8bn. The latest transaction was disclosed on 4 September 2026 (Cease Substantial Holding). Among the most active insiders: There was a change in the interests of the. The full history is accessible without an account.
21
Insider Decl.
n/a
Thresholds
€57,087
5 ops.
Buy Volume
n/a
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Cochlear Limited Hold (neutral), based on 16 analysts. Average price target: A$140.04.
39Σ signal
Buys €57,087n/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 14,099 of 29,063 companies
52.8
score / 100
Value
38
Quality
68
FCF yld3.2%
Earn yld1.7%
EV/EBITDA27.1x
ROE8.0%
Gross mgn71%
Net mgn6.3%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Cochlear Limited es una empresa dedicada al desarrollo de soluciones auditivas innovadoras. Se especializa en implantes cocleares y otras tecnologías para ayudar a personas con pérdida auditiva.